Fate Therapeutics
FATE
#8534
Rank
A$0.23 B
Marketcap
$2.02
Share price
-4.44%
Change (1 day)
-69.50%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$3.27

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.40. In 2022 the company made an earnings per share (EPS) of -$4.55 a decrease over its 2021 EPS that were of -$3.49.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.27-28.16%
2022-$4.5530.49%
2021-$3.497.21%
2020-$3.2545.45%
2019-$2.2419.17%
2018-$1.8817.65%
2017-$1.60-3.77%
2016-$1.66-12.4%
2015-$1.89-3.97%
2014-$1.97-2.09%
2013-$2.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$12.25 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.69-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$13.54 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.85 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.07-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA